You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CO-338-043

Showing 1 - 25 of 5,937
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumor Trial in Akashi, Hidaka, Tsukiji (Rucaparib)

Completed
  • Advanced Solid Tumor
  • Akashi, Hyogo, Japan
  • +2 more
May 16, 2022

Metastatic Castration Resistant Prostate Cancer Trial in Atlanta, Minneapolis, Nashville (Rucaparib, Enzalutamide, Abiraterone)

Active, not recruiting
  • Metastatic Castration Resistant Prostate Cancer
  • Atlanta, Georgia
  • +2 more
Jan 24, 2022

Mesothelioma, Malignant Trial in Leicester (Rucaparib, Abemaciclib, pembrolizumab & bemcentinib)

Recruiting
  • Mesothelioma, Malignant
  • Leicester, United Kingdom
    University Hospitals of Leicester NHS Trust
Apr 6, 2022

Resectable Locally Advanced NSCLC Trial in Nanchang

Not yet recruiting
  • Resectable Locally Advanced Non-small Cell Lung Cancer
  • Nanchang, Jiangxi, China
    The First Affiliated Hospital of Nanchang University
Apr 14, 2021

Breast Cancer, Prostate Cancer, Ovarian Cancer Trial in Worldwide (Part 1, Dose Level 1 and Dose Level 2a: Ipatasertib, Part 1,

Completed
  • Breast Cancer
  • +2 more
  • Part 1, Dose Level 1 and Dose Level 2a: Ipatasertib
  • +3 more
  • San Marcos, California
  • +16 more
Jan 25, 2022

Tuberculosis, Pulmonary, Other Specified Pulmonary Tuberculosis Trial in Cape Town, Mbeya, Mwanza (BTZ-043, Bedaquiline,

Not yet recruiting
  • Tuberculosis, Pulmonary
  • Other Specified Pulmonary Tuberculosis
  • Cape Town, South Africa
  • +3 more
Jun 22, 2023

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in United States (Rucaparib, Nivolumab)

Terminated
Has Results
  • Epithelial Ovarian Cancer
  • +4 more
  • Clovis, California
  • +4 more
May 19, 2021

Gynecologic Tumors Trial in Worldwide (Atezolizumab, Rucaparib)

Completed
  • Gynecologic Neoplasms
  • Melbourne, Victoria, Australia
  • +10 more
Oct 20, 2020

Pulmonary Tuberculoses, Other Specified Pulmonary Tuberculosis Trial in Cape Town (BTZ-043, Rifafour e-275®, Probe Drug

Completed
  • Pulmonary Tuberculoses
  • Other Specified Pulmonary Tuberculosis
  • Cape Town, South Africa
  • +1 more
Aug 9, 2022

Tuberculosis, Tuberculosis, Pulmonary, Bacterial Infections Respiratory Trial in Groningen (500mg BTZ-043 containing 3.7 MBq of

Completed
  • Tuberculosis
  • +4 more
  • 500mg BTZ-043 containing 3.7 MBq of [14C]BTZ-043
  • Groningen, Netherlands
    PRA Health Sciences (PRA) - Early Development Services (EDS)
Oct 19, 2021

Pancreatic Cancer Trial in Philadelphia (RUCAPARIB)

Active, not recruiting
  • Pancreatic Cancer
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Nov 10, 2021

Alpha 1-Antitrypsin Deficiency Trial in Gainesville, Charleston (ADVM-043)

Completed
Has Results
  • Alpha 1-Antitrypsin Deficiency
  • ADVM-043
  • Gainesville, Florida
  • +1 more
Aug 3, 2022

Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer Trial in Worldwide (Chemotherapy, Rucaparib)

Active, not recruiting
Has Results
  • Ovarian Cancer
  • +3 more
  • Denver, Colorado
  • +76 more
Feb 20, 2022

Functional Dyspepsia Trial in Matsumoto (Acotiamide HCl hydrate, Placebo)

Recruiting
  • Functional Dyspepsia
  • Acotiamide hydrochloride hydrate
  • Placebo
  • Matsumoto, Nagano, Japan
    Zeria Investigative Site
Mar 23, 2021

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-cell Marginal Zone, Lymphoma, Non-Hodgkin Trial in Worldwide (LOXO-338,

Active, not recruiting
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • +6 more
  • Duarte, California
  • +8 more
Jan 11, 2023

COVID-19 Trial (GLB-COV2-043, BNT162b2/COMIRNATY®)

Not yet recruiting
  • COVID-19
  • (no location specified)
Oct 31, 2022

Long-term Sequelae of Coronavirus Disease 2019 Pneumonia With

Active, not recruiting
  • COVID-19 Pneumonia
  • +4 more
    • Faro, Portugal
    • +1 more
    Apr 26, 2023

    Metastatic Castration-Resistant Prostate Cancer, Ovarian Cancer, Epithelial Ovarian Cancer Trial in Worldwide (Rucaparib)

    Enrolling by invitation
    • Metastatic Castration-Resistant Prostate Cancer
    • +5 more
    • Lakewood, Colorado
    • +37 more
    Jan 18, 2022

    Hypogonadotropic Hypogonadism Trial in Worldwide (Corifollitropin alfa, hCG)

    Completed
    Has Results
    • Hypogonadotropic Hypogonadism
    • Corifollitropin alfa
    • hCG
    • Curitiba, Brazil
    • +14 more
    Feb 1, 2022

    Primary Generalized Tonic-Clonic or Partial Onset Seizures, Lennox Gastaut Syndrome Trial in Worldwide (Perampanel)

    Available
    • Primary Generalized Tonic-Clonic or Partial Onset Seizures
    • Lennox Gastaut Syndrome
    • Brussels, Belgium
    • +21 more
    May 25, 2022

    Chronic Kidney Disease, Type 2 Diabetes, Obesity Trial in Worldwide (Cagrilintide, Semaglutide, Placebo)

    Not yet recruiting
    • Chronic Kidney Disease
    • +2 more
    • Concord, California
    • +73 more
    Nov 9, 2023

    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in Worldwide (Rucaparib)

    Completed
    Has Results
    • Ovarian Cancer
    • +3 more
    • San Francisco, California
    • +15 more
    Jan 19, 2021

    Chronic Cough Trial in Worldwide (Gefapixant, Placebo)

    Completed
    Has Results
    • Chronic Cough
    • Phoenix, Arizona
    • +90 more
    Sep 19, 2022

    Solid Tumor Trial in Budapest (C-14 labeled Rucaparib, Rucaparib)

    Completed
    • Solid Tumor
    • Budapest, Rottenbiller Utca 13, Hungary
      PRA Magyarország Kft.
    Dec 10, 2019

    THC, Cannabis, Cannabis Use Trial in San Francisco (Cannabis, Nicotine, Pax Loose Leaf Vaporizer)

    Not yet recruiting
    • THC
    • +5 more
    • San Francisco, California
      Zuckerberg San Francisco General Hospital
    Aug 11, 2023